Human MLH1(MutL Homolog 1) ELISA Kit
To Order Contact us: michael@lotusbiotechnologies.com
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
EKU06045-5x96T | Biomatik Corporation | 5x96T | 3770.55 EUR |
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
EKU06045-96T | Biomatik Corporation | 96T | 793.8 EUR |
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
EKN47156-48T | Biomatik Corporation | 48T | 378.7 EUR |
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
EKN47156-5x96T | Biomatik Corporation | 5x96T | 2569.75 EUR |
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
EKN47156-96T | Biomatik Corporation | 96T | 541 EUR |
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
RD-MLH1-Hu-48Tests | Reddot Biotech | 48 Tests | 625.2 EUR |
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
RD-MLH1-Hu-96Tests | Reddot Biotech | 96 Tests | 867.6 EUR |
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
RDR-MLH1-Hu-48Tests | Reddot Biotech | 48 Tests | 652.8 EUR |
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
RDR-MLH1-Hu-96Tests | Reddot Biotech | 96 Tests | 907.2 EUR |
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
DL-MLH1-Hu | DL Develop | 96T | 441 EUR |
Description: tissue homogenates, cell lysates or other biological fluids. |
|||
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
DLR-MLH1-Hu | DL Develop | 96T | 463 EUR |
Description: tissue homogenates, cell lysates or other biological fluids. |
|||
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
SEJ742Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5677.8 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 1 (MLH1) in tissue homogenates, cell lysates and other biological fluids. |
|||
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
SEJ742Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 766.8 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 1 (MLH1) in tissue homogenates, cell lysates and other biological fluids. |
|||
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
RDR-MLH1-Hu-48T | Reddot Biotech | 48T | 475.34 EUR |
Description: tissue homogenates, cell lysates and other biological fluids. |
|||
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
RDR-MLH1-Hu-96T | Reddot Biotech | 96T | 679.04 EUR |
Description: tissue homogenates, cell lysates and other biological fluids. |
|||
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
RD-MLH1-Hu-48T | Reddot Biotech | 48T | 452.7 EUR |
Description: tissue homogenates, cell lysates and other biological fluids. |
|||
Human MutL Homolog 1 (MLH1) ELISA Kit |
|||
RD-MLH1-Hu-96T | Reddot Biotech | 96T | 646.7 EUR |
Description: tissue homogenates, cell lysates and other biological fluids. |
|||
ELISA kit for Human MLH1 (MutL Homolog 1) |
|||
ELK4307 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A sandwich ELISA kit for detection of MutL Homolog 1 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
ELISA Kit for MutL Homolog 1 (MLH1) |
|||
SEJ742Hu | Cloud-Clone | 96Т | 700 EUR |
MLH1 (MutL Homolog 1) |
|||
MO47010 | Neuromics | 100 ul | 418.8 EUR |
Human MutL Homolog 1 (MLH1) CLIA Kit |
|||
20-abx495774 | Abbexa |
|
|
Human MutL Homolog 1 (MLH1) Protein |
|||
20-abx654421 | Abbexa |
|
|
MLH1 (MutL Homolog 1)(MLH1/1324), 0.2mg/mL |
|||
BNUB1324-100 | Biotium | 1uL | 225 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), 0.2mg/mL |
|||
BNUB1324-500 | Biotium | 1uL | 485 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), 1mg/mL |
|||
BNUM1324-50 | Biotium | 1uL | 396 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MutL Homolog 1 (MLH1) Antibody |
|||
20-abx317973 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody |
|||
20-abx241566 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody |
|||
20-abx241567 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody |
|||
abx235213-100ug | Abbexa | 100 ug | 577.2 EUR |
MutL Homolog 1 (MLH1) Antibody |
|||
20-abx173641 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody |
|||
20-abx177638 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody |
|||
20-abx113897 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody |
|||
abx026385-400ul | Abbexa | 400 ul | 627.6 EUR |
MutL Homolog 1 (MLH1) Antibody |
|||
abx026385-80l | Abbexa | 80 µl | 343.2 EUR |
MutL Homolog 1 (MLH1) Antibody |
|||
abx025515-100ul | Abbexa | 100 ul | 627.6 EUR |
MutL Homolog 1 (MLH1) Antibody |
|||
20-abx014046 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody |
|||
20-abx328114 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody |
|||
20-abx002899 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody |
|||
20-abx008989 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody |
|||
20-abx000639 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody |
|||
abx012221-100ul | Abbexa | 100 ul | 493.2 EUR |
MLH1 Antibody / MutL Homolog 1 |
|||
V8749-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
MLH1 Antibody / MutL Homolog 1 |
|||
V8749-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
MLH1 Antibody / MutL Homolog 1 |
|||
V8749SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
MLH1 Antibody / MutL Homolog 1 |
|||
V9166-100UG | NSJ Bioreagents | 100ug | 349.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
MLH1 Antibody / MutL Homolog 1 |
|||
V9166-20UG | NSJ Bioreagents | 20ug | 153.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
MLH1 Antibody / MutL Homolog 1 |
|||
V9166SAF-100UG | NSJ Bioreagents | 100ug | 349.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2). Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
MLH1 Antibody / MutL Homolog 1 |
|||
V9349-100UG | NSJ Bioreagents | 100ug | 349.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
MLH1 Antibody / MutL Homolog 1 |
|||
V9349-20UG | NSJ Bioreagents | 20ug | 153.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
MLH1 Antibody / MutL Homolog 1 |
|||
V9349SAF-100UG | NSJ Bioreagents | 100ug | 349.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
MLH1 Antibody / MutL Homolog 1 |
|||
V4038-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
MLH1 Antibody / MutL Homolog 1 |
|||
V4038-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
MLH1 Antibody / MutL Homolog 1 |
|||
V4038SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This MAb recognizes a protein of 83kDa, identified as MLH1. Defects in MLH1 are the cause of hereditary non-polyposis colorectal cancer type 2 (HNPCC2).Heterodimerizes with PMS2 to form MutL alpha, a component of the post-replicative DNA mismatch repair system (MMR). DNA repair is initiated by MutS alpha (MSH2-MSH6) or MutS beta (MSH2-MSH6) binding to a dsDNA mismatch, then MutL alpha is recruited to the heteroduplex. Assembly of the MutL-MutS-heteroduplex ternary complex in presence of RFC and PCNA is sufficient to activate endonuclease activity of PMS2. It introduces single-strand breaks near the mismatch and thus generates new entry points for the exonuclease EXO1 to degrade the strand containing the mismatch. DNA methylation would prevent cleavage and therefore assure that only the newly mutated DNA strand is going to be corrected. MutL alpha (MLH1-PMS2) interacts physically with the clamp loader subunits of DNA polymerase III, suggesting that it may play a role to recruit the DNA polymerase III to the site of the MMR. Also implicated in DNA damage signaling, a process, which induces cell cycle arrest and can lead to apoptosis in case of major DNA damages. Heterodimerizes with MLH3 to form MutL gamma, which plays a role in meiosis. |
|||
Human MLH3(MutL Homolog 3) ELISA Kit |
|||
ELK7522-48T | ELK Biotech | 48T | Ask for price |
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MLH3. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human MLH3. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human MLH3, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MLH3 in the samples is then determined by comparing the OD of the samples to the standard curve. |
|||
Human MLH3(MutL Homolog 3) ELISA Kit |
|||
ELK7522-96T | ELK Biotech | 96T | Ask for price |
Description: The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human MLH3. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human MLH3. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human MLH3, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human MLH3 in the samples is then determined by comparing the OD of the samples to the standard curve. |
|||
MutL Homolog 1 (MLH1) Antibody (HRP) |
|||
20-abx313263 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody (FITC) |
|||
20-abx313264 | Abbexa |
|
|
MutL Homolog 1 (MLH1) Antibody (Biotin) |
|||
20-abx313265 | Abbexa |
|
|
MLH1 (MutL Homolog 1)(MLH1/1324), CF647 conjugate, 0.1mg/mL |
|||
BNC471324-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), CF647 conjugate, 0.1mg/mL |
|||
BNC471324-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), CF568 conjugate, 0.1mg/mL |
|||
BNC681324-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), CF568 conjugate, 0.1mg/mL |
|||
BNC681324-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), CF594 conjugate, 0.1mg/mL |
|||
BNC941324-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), CF594 conjugate, 0.1mg/mL |
|||
BNC941324-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), CF640R conjugate, 0.1mg/mL |
|||
BNC401324-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), CF640R conjugate, 0.1mg/mL |
|||
BNC401324-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), CF488A conjugate, 0.1mg/mL |
|||
BNC881324-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), CF488A conjugate, 0.1mg/mL |
|||
BNC881324-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), CF405S conjugate, 0.1mg/mL |
|||
BNC041324-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), CF405S conjugate, 0.1mg/mL |
|||
BNC041324-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), Biotin conjugate, 0.1mg/mL |
|||
BNCB1324-100 | Biotium | 1uL | 192 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
MLH1 (MutL Homolog 1)(MLH1/1324), Biotin conjugate, 0.1mg/mL |
|||
BNCB1324-500 | Biotium | 1uL | 532 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
20-abx258180 | Abbexa |
|
|
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
SEL736Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 6227.58 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 3 (MLH3) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
SEL736Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 618.04 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 3 (MLH3) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
SEL736Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 831.48 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 3 (MLH3) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
SEL736Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3381.66 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human MutL Homolog 3 (MLH3) in Tissue homogenates, cell lysates and other biological fluids. |
|||
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
4-SEL736Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human MutL Homolog 3 (MLH3) in samples from Tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
EKN50428-48T | Biomatik Corporation | 48T | 380.31 EUR |
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
EKN50428-5x96T | Biomatik Corporation | 5x96T | 2580.68 EUR |
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
EKN50428-96T | Biomatik Corporation | 96T | 543.3 EUR |
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
EKU09317-48T | Biomatik Corporation | 48T | 610.82 EUR |
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
EKU09317-5x96T | Biomatik Corporation | 5x96T | 4144.85 EUR |
Human MutL Homolog 3 (MLH3) ELISA Kit |
|||
EKU09317-96T | Biomatik Corporation | 96T | 872.6 EUR |
MutL Homolog 1 (MLH1) Magnetic Luminex Assay Kit |
|||
LKU606804-96T | Biomatik Corporation | 96T | 966 EUR |
ELISA kit for Human MLH3 (MutL Homolog 3) |
|||
ELK7522 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A sandwich ELISA kit for detection of MutL Homolog 3 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Mlh1 (GFP-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1) |
|||
MG210511 | Origene Technologies GmbH | 10 µg | Ask for price |
Mlh1 (untagged) - Mouse mutL homolog 1 (E. coli) (Mlh1), (10ug) |
|||
MC221356 | Origene Technologies GmbH | 10 µg | Ask for price |
Mlh1 (Myc-DDK-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1) |
|||
MR210511 | Origene Technologies GmbH | 10 µg | Ask for price |
MutL Protein Homolog 1 (MLH1) (ABT-MLH1) Mouse mAb |
|||
E2251305 | EnoGene | 100ul | 225 EUR |
Description: Available in various conjugation types. |
|||
Mlh1 (untagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), (10 ug) |
|||
RN207442 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (untagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 5 |
|||
SC330648 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (untagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 6 |
|||
SC330650 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (untagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 7 |
|||
SC330651 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (GFP-tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 6 |
|||
RG232898 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (GFP-tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 7 |
|||
RG232899 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (GFP-tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 5 |
|||
RG233081 | Origene Technologies GmbH | 10 µg | Ask for price |
Mlh1 (Myc-DDK-tagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), (10 ug) |
|||
RR207442 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (Myc-DDK tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 6 |
|||
RC232898 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (Myc-DDK tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 7 |
|||
RC232899 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (Myc-DDK tagged) - Homo sapiens mutL homolog 1 (MLH1), transcript variant 5 |
|||
RC233081 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Mlh1 (mGFP-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1) |
|||
MR210511L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Human MutL Homolog 3 (MLH3) CLIA Kit |
|||
20-abx495965 | Abbexa |
|
|
MLH1 (untagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1 |
|||
SC119993 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (untagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1 |
|||
SC323792 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Mlh1 (Myc-DDK-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1) |
|||
MR210511L3 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (GFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1 |
|||
RG201607 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (untagged)-Human mutL homolog 1 colon cancer nonpolyposis type 2 (E. coli) (MLH1) transcript variant 3 |
|||
SC328850 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (untagged)-Human mutL homolog 1 colon cancer nonpolyposis type 2 (E. coli) (MLH1) transcript variant 4 |
|||
SC328851 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (untagged)-Human mutL homolog 1 colon cancer nonpolyposis type 2 (E. coli) (MLH1) transcript variant 2 |
|||
SC329041 | Origene Technologies GmbH | 10 µg | Ask for price |
Human MutL Homolog 1 ELISA Kit |
|||
IHUMLH1KT | Innovative research | each | 733 EUR |
Description: Human MutL Homolog 1 ELISA Kit |
|||
Lenti ORF clone of Mlh1 (mGFP-tagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), (10 ug) |
|||
RR207442L4 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (GFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3 |
|||
RG230212 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (GFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 4 |
|||
RG230213 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (GFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 2 |
|||
RG230403 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1 |
|||
RC201607 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF clone of Mlh1 (Myc-DDK-tagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), (10 ug) |
|||
RR207442L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Mlh1 (GFP-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1), 200ul, >10^7 TU/mL |
|||
MR210511L4V | Origene Technologies GmbH | 200 µl | Ask for price |
MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3 |
|||
RC230212 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 4 |
|||
RC230213 | Origene Technologies GmbH | 10 µg | Ask for price |
MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 2 |
|||
RC230403 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, Mlh1 (GFP-tagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), 200ul, >10^7 TU/mL |
|||
RR207442L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Mlh1 (Myc-DDK-tagged) - Mouse mutL homolog 1 (E. coli) (Mlh1), 200ul, >10^7 TU/mL |
|||
MR210511L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, Mlh1 (Myc-DDK-tagged ORF) - Rat mutL homolog 1 (E. coli) (Mlh1), 200ul, >10^7 TU/mL |
|||
RR207442L3V | Origene Technologies GmbH | 200 µl | Ask for price |
MutL Homolog 3 (MLH3) Antibody |
|||
abx146077-100ug | Abbexa | 100 ug | 469.2 EUR |
MutL Homolog 3 (MLH3) Antibody |
|||
20-abx324670 | Abbexa |
|
|
MutL Homolog 3 (MLH3) Antibody |
|||
abx331047-100ul | Abbexa | 100 ul | 510 EUR |
MutL Homolog 3 (MLH3) Antibody |
|||
20-abx014047 | Abbexa |
|
|
MutL Homolog 3 (MLH3) Antibody |
|||
abx432972-200ul | Abbexa | 200 ul | 343.2 EUR |
MutL Homolog 3 (MLH3) Antibody |
|||
20-abx006534 | Abbexa |
|
|
Lenti ORF particles, MLH1 (mGFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1, 200ul, |
|||
RC201607L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, MLH1 (mGFP-tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1, 200ul, |
|||
RC201607L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti-ORF clone of MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3 |
|||
RC230212L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti-ORF clone of MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 4 |
|||
RC230213L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti-ORF clone of MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 2 |
|||
RC230403L4 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, MLH1 (Myc-DDK tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1, 200u |
|||
RC201607L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, MLH1 (Myc-DDK tagged) - Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 1, 200u |
|||
RC201607L3V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3, 200ul, >1 |
|||
RC230212L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 4, 200ul, >1 |
|||
RC230213L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, MLH1 (mGFP-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 2, 200ul, >1 |
|||
RC230403L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti-ORF clone of MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3 |
|||
RC230212L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti-ORF clone of MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 4 |
|||
RC230213L3 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti-ORF clone of MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 2 |
|||
RC230403L3 | Origene Technologies GmbH | 10 µg | Ask for price |
MutL Homolog 3 (MLH3) Magnetic Luminex Assay Kit |
|||
LKU606805-96T | Biomatik Corporation | 96T | 1062.6 EUR |
MLH3 (untagged)-Human mutL homolog 3 (E. coli) (MLH3), transcript variant 1 |
|||
SC310948 | Origene Technologies GmbH | 10 µg | Ask for price |
Lenti ORF particles, MLH1 (Myc-DDK-tagged)-Human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1), transcript variant 3, 200ul, |
|||
RC230212L3V | Origene Technologies GmbH | 200 µl | Ask for price |